| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
236,000,000 |
| Market
Cap: |
4.30(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.18 - $24.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1088 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
155,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$579,644 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
527,621 |
548,621 |
1,468,844 |
5,652,382 |
| Total Sell Value |
$10,940,389 |
$11,337,709 |
$27,645,922 |
$48,529,250 |
| Total People Sold |
4 |
4 |
7 |
9 |
| Total Sell Transactions |
10 |
11 |
19 |
31 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tade Brad L. |
CFO and Treasurer |
• • – |
2025-06-26 |
4 |
D |
$18.40 |
$181,019 |
D/D |
(9,838) |
246,542 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-06-16 |
4 |
AS |
$20.81 |
$437,010 |
D/D |
(21,000) |
2,043,850 |
|
-11% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-06-16 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,064,850 |
|
- |
|
| Elms Steve |
|
• • – |
2025-06-16 |
4 |
S |
$20.24 |
$3,941,720 |
D/D |
(194,749) |
87,330 |
|
11% |
|
| Elms Steve |
|
• • – |
2025-06-13 |
4 |
S |
$20.82 |
$2,871,723 |
D/D |
(137,931) |
282,079 |
|
13% |
|
| Elms Steve |
|
• • – |
2025-06-13 |
4 |
OE |
$1.67 |
$1,140,763 |
D/D |
332,680 |
420,010 |
|
- |
|
| Elms Steve |
|
• • – |
2025-06-12 |
4 |
S |
$21.69 |
$2,015,890 |
I/I |
(92,941) |
2,031,730 |
|
16% |
|
| Guiheen Lawrence P. |
|
• • – |
2025-06-09 |
4 |
S |
$20.96 |
$419,200 |
D/D |
(20,000) |
94,830 |
|
13% |
|
| Grossman Jerrold B |
|
• • – |
2025-06-09 |
4 |
S |
$21.31 |
$213,100 |
D/D |
(10,000) |
478,194 |
|
13% |
|
| Grossman Jerrold B |
|
• • – |
2025-06-09 |
4 |
OE |
$5.00 |
$50,000 |
D/D |
10,000 |
488,194 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2025-05-22 |
4 |
S |
$20.12 |
$24,567 |
D/D |
(1,221) |
114,830 |
|
10% |
|
| Guiheen Lawrence P. |
|
• • – |
2025-05-22 |
4 |
OE |
$5.96 |
$7,277 |
D/D |
1,221 |
116,051 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2025-05-21 |
4 |
S |
$20.32 |
$158,069 |
D/D |
(7,779) |
114,830 |
|
10% |
|
| Guiheen Lawrence P. |
|
• • – |
2025-05-21 |
4 |
OE |
$5.96 |
$46,363 |
D/D |
7,779 |
122,609 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-05-15 |
4 |
AS |
$19.45 |
$408,450 |
D/D |
(21,000) |
2,049,850 |
|
-5% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-05-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,070,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-04-15 |
4 |
AS |
$21.46 |
$450,660 |
D/D |
(21,000) |
2,055,850 |
|
-18% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-04-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,076,850 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-04-01 |
4 |
D |
$19.42 |
$367,426 |
D/D |
(18,920) |
490,425 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-03-19 |
4 |
AS |
$18.92 |
$397,320 |
D/D |
(21,000) |
2,061,850 |
|
-12% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-03-19 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,082,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-03-07 |
4 |
D |
$17.02 |
$502,311 |
D/D |
(29,513) |
2,067,850 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-03-07 |
4 |
D |
$17.02 |
$66,974 |
D/D |
(3,935) |
509,345 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-03-06 |
4 |
D |
$16.91 |
$954,367 |
D/D |
(56,438) |
2,097,363 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-03-06 |
4 |
D |
$16.91 |
$150,178 |
D/D |
(8,881) |
513,280 |
|
- |
|
234 Records found
|
|
Page 1 of 10 |
|
|
0.05 (0.28%) 
